Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 24973859 | HLA (HLA) | stem cell transplantation | French | NA | NA | unclassified | |
| [allogeneic stem cell transplantation from an hla-haploidentical related donor: sfgm-tc recommendations (part 1)]. | |||||||
| 24973859 | HLA (HLA) | stem cell transplantation | French | NA | NA | unclassified | |
| this is part one of the recommendations regarding allogeneic stem cell transplantation from an hla-haploidentical related donor. | |||||||
| 25148373 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | Mexican | NA | NA | negative | |
| patients and methods six consecutive aa-pnh patients with hla-identical siblings were allografted in two institutions in mexico, employing a reduced-intensity conditioning regimen for stem cell transplantation (rist) conducted on an outpatient basis. | |||||||
| 25150256 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| minor histocompatibility antigens are highly immunogeneic polymorphic peptides playing crucial roles in the clinical outcome of hla-identical allogeneic stem cell transplantation. | |||||||
| 25200500 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| the only proven curative therapy for patients with scd is myeloablative conditioning and allogeneic stem cell transplantation from hla-matched sibling donors. | |||||||
| 25255162 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | Spanish | NA | NA | unclassified | |
| among the strategies to optimize engraftment of cord blood (cb) stem cell transplantation (sct), single cb with the coinfusion of cd34(+) stem cells from an hla-mismatched auxiliary donor (haplo-cord) provides a valid alternative for adult patients without a suitable donor. | |||||||
| 25278457 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the blood and marrow transplant clinical trials network (bmt ctn). | |||||||
| 25307958 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | cyclophosphamide | NA | negation | |
| haploidentical stem cell transplantation (haplosct) is an attractive option for patients requiring a hematopoietic stem cell transplant who do not have an hla-matched donor, because it is cheaper, can be performed faster, and may extend transplantation to virtually all patients in need. | |||||||
| 25378968 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | eltrombopag | NA | unclassified | |
| allogeneic stem cell transplantation (sct) from hla-matched sibling donor (msd-sct) is a preferred first-line treatment option for younger patients with severe or very severe aa, whereas immunosuppressive treatment (ist) is an alternative option for others. | |||||||
| 25450788 | HLA-DQB1 (HLA-DQB1) | stem cell transplantation | Austrian | NA | NA | unclassified | |
| the loci cover the hla-coding region from hla-a to hla-dqb1 and can be used for a better definition of hla haplotypes for population and disease association studies, recombination point mapping, haematopoietic stem cell transplantation as well as for identity and relationship testing. | |||||||
Copyright 2024